Genotypic analysis of genes associated with isoniazid and ethionamide resistance in MDR-TB isolates from Thailand

Clinical Microbiology and Infection

Volumn 16, Issue 4, 2010, Pages 396-399

  Boonaiam, S ^a   Chaiprasert, A ^a   Prammananan, T ^a,b   Leechawengwongs, M ^a,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b National Centre for Genetic Engineering and Biotechnology

^c Vichaiyut Hospital   (Thailand)

Author keywords

Ethionamide resistance; isoniazid resistance; MDR TB; Mycobacterium tuberculosis; Thailand

Indexed keywords

BACTERIAL PROTEIN; CATALASE; ETHIONAMIDE; ISONIAZID; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

ARTICLE; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; SEQUENCE ANALYSIS; THAILAND;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHIONAMIDE; GENOTYPE; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; SEQUENCE ANALYSIS; THAILAND; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 85031343612     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02838.x     Document Type: Article

References (20)

1. Ramaswamy, S, Musser, JM, Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79 (1998), 3–29.
2. Miesel, L, Weisbrod, TR, Marcinkeviciene, JA, Bittman, R, Jacobs, WR Jr, NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis. J Bacteriol 180 (1998), 2459–2467.
3. Lee, AS, Teo, AS, Wong, SY, Novel mutations in ndh in isoniazid‐resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 45 (2001), 2157–2159.
4. + ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob Agents Chemother 49 (2005), 708–720.
5. Musser, JM, Kapur, V, Williams, DL, Kreiswirth, BN, Van Soolingen, D, Van Embden, JD, Characterization of the catalase‐peroxidase gene (katG) and inhA locus in isoniazid‐resistant and ‐susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 173 (1996), 196–202.
6. Haas, WH, Schilke, K, Brand, J, et al. Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob Agents Chemother 41 (1997), 1601–1603.
7. Ramaswamy, SV, Reich, R, Dou, SJ, et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 47 (2003), 1241–1250.
8. DeBarber, AE, Mdluli, K, Bosman, M, Bekker, LG, Barry, CE 3rd, Ethionamide activation and sensitivity in multidrug‐resistant Mycobacterium tuberculosis. Proc Natl Acad Sci USA 97 (2000), 9677–9682.
9. Baulard, AR, Betts, JC, Engohang‐Ndong, J, et al. Activation of the pro‐drug ethionamide is regulated in mycobacteria. J Biol Chem 275 (2000), 28326–28331.
10. Woods, G, Brown‐Elliott, BA, Desmond, EP, et al. Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic Actinomycetes: approved standard. NCCLS document M24-A 23 (2003), 5–11.
11. Imwidthaya, P, Mieskes, K, Rienthong, S, Evaluation of katG codon 315 mutations among isoniazid sensitive and resistant Mycobacterium tuberculosis isolates from Thailand. J Med Assoc Thai 84 (2001), 864–869.
12. Khadka, DK, Eampokalap, B, Panitchakorn, J, Ramasoota, P, Khusmith, S, Multiple mutations in katG and inhA identified in Thai isoniazid‐resistant Mycobacterium tuberculosis isolates. Southeast Asian J Trop Med Public Health 38 (2007), 376–382.
13. Kim, SY, Park, YJ, Kim, WI, et al. Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea. Diagn Microbiol Infect Dis 47 (2003), 497–502.
14. Morlock, GP, Metchock, B, Sikes, D, Crawford, JT, Cooksey, RC, ethA, inhA, and katG loci of ethionamide‐resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 47 (2003), 3799–3805.
15. Herrera, L, Valverde, A, Saiz, P, Saez‐Nieto, JA, Portero, JL, Jimenez, MS, Molecular characterization of isoniazid‐resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines. Int J Antimicrob Agents 23 (2004), 572–576.
16. Paca‐uccaralertkun, S, Chuehottaworn, C, katG mutations in isoniazid resistant Mycobacterium tuberculosis isolates from Thai patients. Southeast Asian J Trop Med Public Health 28 (1997), 387–390.
17. Sreevatsan, S, Pan, X, Stockbauer, KE, et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA 94 (1997), 9869–9874.
18. Telenti, A, Honore, N, Bernasconi, C, et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 35 (1997), 719–723.
19. Sreevatsan, S, Pan, X, Zhang, Y, Deretic, V, Musser, JM, Analysis of the oxyR–ahpC region in isoniazid‐resistant and ‐susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob Agents Chemother 41 (1997), 600–606.
20. Kelly, CL, Rouse, DA, Morris, SL, Analysis of ahpC gene mutations in isoniazid‐resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 41 (1997), 2057–2058.